Immuno-oncology

The Pharmacy Times® Immuno-oncology Resource Center is a comprehensive resource for clinical news and expert insights on treatments that harness the body's immune system to fight cancer.

Latest News

Image credit: wladimir1804 | stock.adobe.com
FDA Approves Shorter Manufacturing Process for CAR T-cell Therapy Axicabtagene Ciloleucel

January 31st 2024

Less manufacturing time could be the difference between a patient receiving this life-saving therapy vs not.

catalin - stock.adobe.com
Neoadjuvant Nivolumab May Boost Survival Outcomes in Patients With Renal Cell Carcinoma

January 30th 2024

Image credit: peterschreiber.media | stock.adobe.com
ADC Drug Candidate Enters Phase 3 Trial for the Treatment of HER2-Low Breast Cancer

January 25th 2024

Image Credit: © wladimir1804 - stock.adobe.com
FDA Updates Label for Axicabtagene Ciloleucel for R/R LBCL Following Positive Long-Term Survival Data

December 22nd 2023

The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects
The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects

December 8th 2023

Video Interviews
Latest CME Events & Activities

Optimizing Administration of CAR T-Cell Therapy in Multiple Myeloma Through Pharmacist Interventions

1.0 Credit / Oncology

View More

Managed Care Insights on Optimizing the Use of BCMA-Targeted Treatments in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

Understanding the Role of BCMA-Directed Therapy in the Management of Relapsed/Refractory Multiple Myeloma

1.25 Credits / Hematology, Oncology

View More

Clinical Updates in the Treatment of HER2-Positive Breast Cancer

0.75 Credit / Oncology, Women's Health

View More

The Evolving Treatment Landscape for HR+/HER2- Breast Cancer: Updates and Considerations for Managed Care

1.5 Credits / Oncology, Women's Health

View More

Exploring Clinical Updates in HR+/HER2- Breast Cancer Treatment and the Impact on Patient Care

1.0 Credit / Oncology, Women’s Health

View More

BCMA-Targeted Treatments in Multiple Myeloma: Novel Approaches and Recent Advances

2.0 Credits / Oncology

View More

Clinical Conversations in Cancer Care: Preparing Pharmacists to Optimize Use of Bispecific Antibodies

1.5 Credits / Hematology, Oncology

View More

Innovations in Cancer Care: Examining the Emerging Role of Bispecific Antibodies in Relapsed/Refractory Lymphoma and Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

An In-depth Look at PARP Inhibitors and Their Role in the Treatment of Ovarian Cancer

1.5 Credits / Oncology, Women's Health

View More

Antibody-Drug Conjugates (ADCs): The Implications of Emerging Trends on Oncology Pharmacy Practice

0.75 Credit / Oncology

View More

Advancing Treatment Options for Endometrial Cancer: Updates for Pharmacists

0.75 Credit / Oncology, Women's Health

View More

Managed Care Approaches in Optimizing the Impact of PARP Inhibitors on Resource Utilization and Clinical Outcomes in Ovarian Cancer

1.5 Credits / Oncology, Women's Health

View More

Promoting Evidence-Based Care and Health Equity in Endometrial Cancer Through Managed Care Interventions

1.0 Credit / Oncology; Women’s Health

View More

Evaluating Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancer

2.0 Credits / Oncology

View More

Preventing and Managing Controlled Substance Diversion Across Health Care Settings

2.0 Credits / Law

View More

Drug Resistance and Toxicity Mitigation Strategies: Optimizing the Role of the Pharmacist in Management of Patients With Chronic Myeloid Leukemia

2.0 Credits / Oncology

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

Exploring the New Standard of Care for the Frontline Treatment of Non-Small Cell Lung Cancer: A Focus on Immunotherapy

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

Optimizing the Use of Targeted Therapies for the Treatment of ROS1-Rearranged and KRAS-Mutant Non−Small Cell Lung Cancer

1.0 Credits / Oncology

View More

2022 ASH Annual Meeting Coverage—Recent Developments in Diffuse Large B-Cell Lymphoma: Insights and Application for Managed Care

1.0 Credit / Oncology

View More

An Article in the American Journal of Managed Care’s Evidence-Based Oncology: Navigating the Complexities of Frontline Immunotherapy in NSCLC

2 Credits / Oncology, Pulmonology/Respiratory

View More

CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care

1.5 Credits / Hematology, Oncology

View More

Evidence-Based Oncology: Discerning Novel Approaches, Recent Advances, and the Managed Care Considerations for Targeted Treatments in CLL

2.0 Credits / Hematology, Oncology

View More

Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and Equitable Care in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

Evidence and Managed Care Considerations for the Use of Novel Immunotherapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

1.5 Credits / Oncology

View More

Leveraging Managed Care to Optimize Patient Outcomes in Acute Myeloid Leukemia

1.5 Credits / Hematology, Oncology

View More

New Pathways in Care for Myelofibrosis: Optimizing Treatment to Improve Outcomes

1.5 Credits / Hematology, Oncology

View More

Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient Care

1.0 Credit / Hematology, Oncology

View More

Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.